Who We Are
Natural products from bacteria represent one of the largest sources of pharmaceuticals throughout the history of medicine. Microbial Pharmaceuticals has developed a platform, metabologenomics, that allows us to study all of the compounds that a class of bacteria produces rather than focusing on a single compound at a time. This leads to the identification of totally new compounds, new but similar to known compounds (called derivatives), and known compounds. We can group all the related compounds together and provide a visual network through NPkinect, our innovative software, to allow partners to browse our library and select the compounds that they are interested in studying. These natural products could be used as lead compounds for the development of pharmaceuticals or used for gaining a better understanding of how diseases (such as cancer) can be targeted for treatment.